2015 Nov 43 11):2479 502. Introduction: Treatment withdrawal in intensive care is common(1).
Analgesic prescribing for musculoskeletal complaints in the ambulatory care setting after the introduction and withdrawal of cyclooxygenase-2 inhibitors.
Objective: This study was undertaken to quantitatively estimate the effect of a rapid introduction or withdrawal of on-demand epidural analgesia on the cesarean delivery rate.
However, while this might be the case, a secondary peak remains a possibility, and this has to be taken into account when decisions are made about the introduction or withdrawal of control measures.
On a single-case level, experimental manipulation of the mediator can be achieved through a (sequence of) treatment introduction and withdrawal design (Barlow et al. 2009).
Because of the small dimensions of the devices, fluid flow is typically laminar, permitting the introduction and withdrawal of individual or combinatorial signals (e.g. growth factors and cytokines) in a systematic and well-defined manner.
Based on our review and experience, we have developed general guidance addressing the five phases of extubation outside the IC setting: (i) introduction of withdrawal, (ii) preparation pretransfer, (iii) extubation, (iv) care postextubation and (v) care postdeath.
We identified the need for local written guidance supporting healthcare professionals planning and undertaking extubation outside the intensive care setting, addressing the following phases: (i) introduction of withdrawal, (ii) preparation pretransfer, (iii) extubation, (iv) care postextubation and (v) care postdeath.
Moreover, for each study participant the number of discrepancies between pre-admission and discharge medication (i.e. temporary or permanent introduction or withdrawal of a drug, alteration of dose and/or frequency including switching between regular and pro re nata application schemes, therapeutic drug substitutions) was determined.
